| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2023 |
SC 13G/A
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 10.4% stake in Crinetics Pharmaceuticals, Inc. |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/13/2022 |
SC 13G/A
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 4.8% stake in First Light Acquisition Group, Inc. |
| 10/11/2022 |
SC 13G/A
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 24.2% stake in First Light Acquisition Group, Inc. |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/15/2022 |
SC 13G
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 12.9% stake in The Real Good Food Company, Inc. |
| 06/13/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/08/2022 |
SC 13G/A
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 4.7% stake in CHANNELADVISOR CORP |
| 02/14/2022 |
SC 13G/A
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 2.8% stake in Cytokinetics, Inc. |
| 02/14/2022 |
SC 13G
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 5.2% stake in First Light Acquisition Group, Inc. |
| 02/14/2022 |
SC 13G
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 5.6% stake in DICE Therapeutics, Inc. |
| 02/14/2022 |
SC 13G
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 8.5% stake in Elevation Oncology, Inc. |
| 02/14/2022 |
SC 13G
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 6% stake in Xenon Pharmaceuticals Inc. |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/10/2022 |
SC 13G
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 10.1% stake in Crinetics Pharmaceuticals, Inc. |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/04/2021 |
SC 13G/A
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 2.3% stake in RumbleOn, Inc. |
| 08/23/2021 |
SC 13G/A
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 0% stake in ESSA Pharma Inc |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|